Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NNRTI binding site is a hydrophobic pocket on the p66 subunit of HIV-1 reverse transcriptase. It is the target for non-nucleoside reverse transcriptase inhibitors (NNRTIs), which are allosteric inhibitors that bind to this site and induce conformational changes in RT, thereby inhibiting its enzymatic activity and preventing viral replication. The plasticity of this pocket and the emergence of resistance mutations are major challenges in HIV therapy.
Allosteric inhibition of reverse transcriptase
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIV-1 Reverse Transcriptase (NNRTI Binding Site) (NNRTI Binding Site).